Amy Y X Yu
Overview
Explore the profile of Amy Y X Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
902
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kapral M, Porter J, Kurdyak P, Yu A, Matheson E, Fang J, et al.
J Am Heart Assoc
. 2024 Jul;
13(15):e035589.
PMID: 39056334
Background: People with schizophrenia are less likely than those without to be treated for cardiovascular disease. We aimed to evaluate the association between schizophrenia and secondary preventive care after ischemic...
12.
Katsanos A, Poppe A, Swartz R, Mandzia J, Catanese L, Shankar J, et al.
Stroke
. 2024 Jul;
55(8):2103-2112.
PMID: 39038099
Background: Interhospital transfer for patients with stroke due to large vessel occlusion for endovascular thrombectomy (EVT) has been associated with treatment delays. Methods: We analyzed data from Optimizing Patient Treatment...
13.
Coutts S, Ankolekar S, Appireddy R, Arenillas J, Assis Z, Bailey P, et al.
Lancet
. 2024 May;
403(10444):2597-2605.
PMID: 38768626
Background: Individuals with minor ischaemic stroke and intracranial occlusion are at increased risk of poor outcomes. Intravenous thrombolysis with tenecteplase might improve outcomes in this population. We aimed to test...
14.
Yu A, Austin P, Jackevicius C, Chu A, Holodinsky J, Hill M, et al.
J Am Heart Assoc
. 2024 Apr;
13(8):e034118.
PMID: 38563374
Background: In the wake of pandemic-related health decline and health care disruptions, there are concerns that previous gains for cardiovascular risk factors may have stalled or reversed. Population-level excess burden...
15.
Joundi R, King J, Stang J, Nicol D, Hill M, Yu A, et al.
Can J Neurol Sci
. 2024 Mar;
52(1):59-67.
PMID: 38532570
Objective: To examine the association of co-morbidity with home-time after acute stroke and whether the association is influenced by age. Methods: We conducted a province-wide study using linked administrative databases...
16.
Yu A, Austin P, Park A, Fang J, Hill M, Kamal N, et al.
Can J Neurol Sci
. 2024 Mar;
52(1):53-58.
PMID: 38443764
Background: Stroke outcomes research requires risk-adjustment for stroke severity, but this measure is often unavailable. The Passive Surveillance Stroke SeVerity (PaSSV) score is an administrative data-based stroke severity measure that...
17.
Ospel J, Zerna C, Harrison E, Kleinig T, Puetz V, Kaiser D, et al.
Can J Neurol Sci
. 2024 Feb;
:1-8.
PMID: 38403588
Background And Purpose: To assess cost-effectiveness of late time-window endovascular treatment (EVT) in a clinical trial setting and a "real-world" setting. Methods: Data are from the randomized ESCAPE trial and...
18.
Kim D, Singh N, Catanese L, Yu A, Demchuk A, Lloret-Villas M, et al.
Stroke
. 2024 Jan;
55(2):288-295.
PMID: 38174568
Background: Understanding sex differences in stroke care is important in reducing potential disparities. Our objective was to explore sex differences in workflow efficiency, treatment efficacy, and safety in the AcT...
19.
20.
Yu A, Kapral M, Park A, Fang J, Hill M, Kamal N, et al.
Med Care
. 2023 Nov;
62(11):741-747.
PMID: 37962442
Background: Adjustment for baseline stroke severity is necessary for accurate assessment of hospital performance. We evaluated whether adjusting for the Passive Surveillance Stroke SeVerity (PaSSV) score, a measure of stroke...